Upgrade to SI Premium - Free Trial

Krystal Biotech (KRYS) Selected as a 'Top Pick' for 2021 by Chardan Capital, Sees 3-4 Major Catalysts

January 15, 2021 10:32 AM
Chardan analyst Gbola Amusa has selected Krystal Biotech (NASDAQ: KRYS) as their “Top Pick” for 2021 as he believes 3 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments